FDA Rejects Auxilium Bid To Hamstring Rival Product
The U.S. Food and Drug Administration has shot down efforts by Auxilium Pharmaceuticals Inc. to hamstring a testosterone product made by Upsher-Smith Laboratories Inc., finding no justification for proposed labeling restrictions,...To view the full article, register now.
Already a subscriber? Click here to view full article